{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:22:32Z","timestamp":1793701352798,"version":"4.5.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammatory liver disease increases the risk of developing primary liver cancer. The mechanism through which liver disease induces tumorigenesis remains unclear, but is thought to occur via increased mutagenesis. Here, we performed whole-genome sequencing on clonally expanded single liver stem cells cultured as intrahepatic cholangiocyte organoids (ICOs) from patients with alcoholic cirrhosis, non-alcoholic steatohepatitis (NASH), and primary sclerosing cholangitis (PSC). Surprisingly, we find that these precancerous liver disease conditions do not result in a detectable increased accumulation of mutations, nor altered mutation types in individual liver stem cells. This finding contrasts with the mutational load and typical mutational signatures reported for liver tumors, and argues against the hypothesis that liver disease drives tumorigenesis via a direct mechanism of induced mutagenesis. Disease conditions in the liver may thus act through indirect mechanisms to drive the transition from healthy to cancerous cells, such as changes to the microenvironment that favor the outgrowth of precancerous cells.<\/jats:p>","DOI":"10.1038\/s42003-021-02839-y","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T11:06:20Z","timestamp":1637233580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Precancerous liver diseases do not cause increased mutagenesis in liver stem cells"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2788-6625","authenticated-orcid":false,"given":"Luan","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-1715","authenticated-orcid":false,"given":"Myrthe","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7848-3933","authenticated-orcid":false,"given":"Ruby","family":"Lieshout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra E.","family":"de Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro D.","family":"Locati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-4441","authenticated-orcid":false,"given":"Nicolle","family":"Besselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8985-8964","authenticated-orcid":false,"given":"Bastiaan","family":"van der Roest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-5350","authenticated-orcid":false,"given":"Roel","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3517-2684","authenticated-orcid":false,"given":"Sander","family":"Boymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3558-1039","authenticated-orcid":false,"given":"Jan N. M.","family":"IJzermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-840X","authenticated-orcid":false,"given":"Michail","family":"Doukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M. A.","family":"Verstegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1285-2836","authenticated-orcid":false,"given":"Ruben","family":"van Boxtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-5334","authenticated-orcid":false,"given":"Luc J. W.","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-9542","authenticated-orcid":false,"given":"Edwin","family":"Cuppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1385-6516","authenticated-orcid":false,"given":"Ewart","family":"Kuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"2839_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal, A. et al. Global cancer statistics. Cancer J. Clin. 61, 69\u201390 (2011).","journal-title":"Cancer J. Clin."},{"key":"2839_CR2","first-page":"201","volume":"38","author":"SF Altekruse","year":"2011","unstructured":"Altekruse, S. F., Devesa, S. S., Dickie, L. A., McGlynn, K. A. & Kleiner, D. E. Histological classification of liver and intrahepatic bile duct cancers in SEER registries. J. Registry Manage. 38, 201\u2013205 (2011).","journal-title":"J. Registry Manage."},{"key":"2839_CR3","doi-asserted-by":"crossref","first-page":"15943","DOI":"10.3748\/wjg.v20.i43.15943","volume":"20","author":"G Testino","year":"2014","unstructured":"Testino, G., Leone, S. & Borro, P. Alcohol and hepatocellular carcinoma: a review and a point of view. World J. Gastroenterol. 20, 15943\u201315954 (2014).","journal-title":"World J. Gastroenterol."},{"key":"2839_CR4","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537\u20132564 (2021).","journal-title":"Cell"},{"key":"2839_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","volume":"17","author":"N Wongjarupong","year":"2017","unstructured":"Wongjarupong, N. et al. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 17, 149 (2017).","journal-title":"BMC Gastroenterol."},{"key":"2839_CR6","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","volume":"54","author":"N Razumilava","year":"2011","unstructured":"Razumilava, N., Gores, G. J. & Lindor, K. D. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54, 1842\u20131852 (2011).","journal-title":"Hepatology"},{"key":"2839_CR7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2013.07.033","volume":"345","author":"X-Y Duan","year":"2014","unstructured":"Duan, X.-Y., Zhang, L., Fan, J.-G. & Qiao, L. NAFLD leads to liver cancer: do we have sufficient evidence? Cancer Lett. 345, 230\u2013234 (2014).","journal-title":"Cancer Lett."},{"key":"2839_CR8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-020-2059-5","volume":"579","author":"MR Hodskinson","year":"2020","unstructured":"Hodskinson, M. R. et al. Alcohol-derived DNA crosslinks are repaired by two distinct mechanisms. Nature 579, 603\u2013608 (2020).","journal-title":"Nature"},{"key":"2839_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3164\/jcbn.14-12","volume":"55","author":"M Tamura","year":"2014","unstructured":"Tamura, M., Ito, H., Matsui, H. & Hyodo, I. Acetaldehyde is an oxidative stressor for gastric epithelial cells. J. Clin. Biochem. Nutr. 55, 26\u201331 (2014).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"2839_CR10","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1530-0277.2006.00171.x","volume":"30","author":"G Novitskiy","year":"2006","unstructured":"Novitskiy, G., Traore, K., Wang, L., Trush, M. A. & Mezey, E. Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. Alcohol. Clin. Exp. Res. 30, 1429\u20131435 (2006).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"2839_CR11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.dnarep.2010.03.004","volume":"9","author":"B van Loon","year":"2010","unstructured":"van Loon, B., Markkanen, E. & H\u00fcbscher, U. Oxygen as a friend and enemy: How to combat the mutational potential of 8-oxo-guanine. DNA Repair 9, 604\u2013616 (2010).","journal-title":"DNA Repair"},{"key":"2839_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-1110(79)90004-6","volume":"65","author":"G Obe","year":"1979","unstructured":"Obe, G. & Ristow, H. Mutagenic, cancerogenic and teratogenic effects of alcohol. Mutat. Res. 65, 229\u2013259 (1979).","journal-title":"Mutat. Res."},{"key":"2839_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-7992(91)90124-M","volume":"264","author":"A Helander","year":"1991","unstructured":"Helander, A. & Lindahl-Kiessling, K. Increased frequency of acetaldehyde-induced sister-chromatic exchanges in human lymphocytes treated with an aldehyde dehydrogenase inhibitor. Mutat. Res. Lett. 264, 103\u2013107 (1991).","journal-title":"Mutat. Res. Lett."},{"key":"2839_CR14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/nar\/26.7.1769","volume":"26","author":"T Matsuda","year":"1998","unstructured":"Matsuda, T., Kawanishi, M., Matsui, S., Yagi, T. & Takebe, H. Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases. Nucleic Acids Res. 26, 1769\u20131774 (1998).","journal-title":"Nucleic Acids Res."},{"key":"2839_CR15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-019-1670-9","volume":"574","author":"SF Brunner","year":"2019","unstructured":"Brunner, S. F. et al. Somatic mutations and clonal dynamics in healthy and cirrhotic human liver. Nature 574, 538\u2013542 (2019).","journal-title":"Nature"},{"key":"2839_CR16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","volume":"10","author":"GA Michelotti","year":"2013","unstructured":"Michelotti, G. A., Machado, M. V. & Diehl, A. M. NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10, 656\u2013665 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2839_CR17","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson, J. K., Beuers, U., Jones, D. E. J., Lohse, A. W. & Hudson, M. Primary sclerosing cholangitis. Lancet 391, 2547\u20132559 (2018).","journal-title":"Lancet"},{"key":"2839_CR18","doi-asserted-by":"crossref","unstructured":"Kawanishi, S., Ohnishi, S., Ma, N., Hiraku, Y. & Murata, M. Crosstalk between DNA damage and inflammation in the multiple steps of carcinogenesis. Int. J. Mol. Sci. 18, 1808 (2017).","DOI":"10.3390\/ijms18081808"},{"key":"2839_CR19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature19768","volume":"538","author":"F Blokzijl","year":"2016","unstructured":"Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538, 260\u2013264 (2016).","journal-title":"Nature"},{"key":"2839_CR20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"2839_CR21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1913-9","volume":"578","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112\u2013121 (2020).","journal-title":"Nature"},{"key":"2839_CR22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ng.3378","volume":"47","author":"K Chan","year":"2015","unstructured":"Chan, K. et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat. Genet. 47, 1067\u20131072 (2015).","journal-title":"Nat. Genet."},{"key":"2839_CR23","volume":"11","author":"L Nguyen","year":"2020","unstructured":"Nguyen, L., Martens, J. W. M., Van Hoeck, A. & Cuppen, E. Pan-cancer landscape of homologous recombination deficiency. Nat. Commun. 11, 5584 (2020).","journal-title":"Nat. Commun."},{"key":"2839_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47\u201354 (2016).","journal-title":"Nature"},{"key":"2839_CR25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","volume":"580","author":"C Pleguezuelos-Manzano","year":"2020","unstructured":"Pleguezuelos-Manzano, C. et al. Mutational signature in colorectal cancer caused by genotoxic pks E. coli. Nature 580, 269\u2013273 (2020).","journal-title":"Nature"},{"key":"2839_CR26","volume":"11","author":"E Kuijk","year":"2020","unstructured":"Kuijk, E. et al. The mutational impact of culturing human pluripotent and adult stem cells. Nat. Commun. 11, 2493 (2020).","journal-title":"Nat. Commun."},{"key":"2839_CR27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","volume":"177","author":"JE Kucab","year":"2019","unstructured":"Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. Cell 177, 821\u2013836.e16 (2019).","journal-title":"Cell"},{"key":"2839_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12594-8","volume":"10","author":"S Christensen","year":"2019","unstructured":"Christensen, S. et al. 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer. Nat. Commun. 10, 4571 (2019).","journal-title":"Nat. Commun."},{"key":"2839_CR29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stem.2019.07.002","volume":"25","author":"Y Post","year":"2019","unstructured":"Post, Y. & Clevers, H. Defining adult stem cell function at its simplest: the ability to replace lost cells through mitosis. Cell Stem Cell 25, 174\u2013183 (2019).","journal-title":"Cell Stem Cell"},{"key":"2839_CR30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature23015","volume":"547","author":"A Raven","year":"2017","unstructured":"Raven, A. et al. Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration. Nature 547, 350\u2013354 (2017).","journal-title":"Nature"},{"key":"2839_CR31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.stem.2021.04.005","volume":"28","author":"A Marsee","year":"2021","unstructured":"Marsee, A. et al. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell 28, 816\u2013832 (2021).","journal-title":"Cell Stem Cell"},{"key":"2839_CR32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2015","unstructured":"Huch, M. et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 299\u2013312 (2015).","journal-title":"Cell"},{"key":"2839_CR33","doi-asserted-by":"crossref","DOI":"10.1038\/srep22154","volume":"6","author":"EW Kuijk","year":"2016","unstructured":"Kuijk, E. W. et al. Generation and characterization of rat liver stem cell lines and their engraftment in a rat model of liver failure. Sci. Rep. 6, 22154 (2016).","journal-title":"Sci. Rep."},{"key":"2839_CR34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","volume":"152","author":"D Sia","year":"2017","unstructured":"Sia, D., Villanueva, A., Friedman, S. L. & Llovet, J. M. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152, 745\u2013761 (2017).","journal-title":"Gastroenterology"},{"key":"2839_CR35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"2839_CR36","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/annonc\/mdy011","volume":"29","author":"XC Li","year":"2018","unstructured":"Li, X. C. et al. A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma. Ann. Oncol. 29, 938\u2013944 (2018).","journal-title":"Ann. Oncol."},{"key":"2839_CR37","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/ijc.23901","volume":"123","author":"T-M Kim","year":"2008","unstructured":"Kim, T.-M. et al. Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int. J. Cancer 123, 2808\u20132815 (2008).","journal-title":"Int. J. Cancer"},{"key":"2839_CR38","volume":"4","author":"CM Court","year":"2020","unstructured":"Court, C. M. et al. Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells. NPJ Precis. Oncol. 4, 16 (2020).","journal-title":"NPJ Precis. Oncol."},{"key":"2839_CR39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41575-020-0284-x","volume":"17","author":"R Donne","year":"2020","unstructured":"Donne, R., Saroul-A\u00efnama, M., Cordier, P., Celton-Morizur, S. & Desdouets, C. Polyploidy in liver development, homeostasis and disease. Nat. Rev. Gastroenterol. Hepatol. 17, 391\u2013405 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2839_CR40","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899\u2013905 (2010).","journal-title":"Nature"},{"key":"2839_CR41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41576-019-0209-0","volume":"21","author":"M Gasperini","year":"2020","unstructured":"Gasperini, M., Tome, J. M. & Shendure, J. Towards a comprehensive catalogue of validated and target-linked human enhancers. Nat. Rev. Genet. 21, 292\u2013310 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"2839_CR42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14853-5","volume":"11","author":"N Doni Jayavelu","year":"2020","unstructured":"Doni Jayavelu, N., Jajodia, A., Mishra, A. & Hawkins, R. D. Candidate silencer elements for the human and mouse genomes. Nat. Commun. 11, 1061 (2020).","journal-title":"Nat. Commun."},{"key":"2839_CR43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium.","year":"2020","unstructured":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020).","journal-title":"Nature"},{"key":"2839_CR44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01358-x","volume":"8","author":"E Letouz\u00e9","year":"2017","unstructured":"Letouz\u00e9, E. et al. Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis. Nat. Commun. 8, 1315 (2017).","journal-title":"Nat. Commun."},{"key":"2839_CR45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng.3547","volume":"48","author":"A Fujimoto","year":"2016","unstructured":"Fujimoto, A. et al. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat. Genet. 48, 500\u2013509 (2016).","journal-title":"Nat. Genet."},{"key":"2839_CR46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1126\/science.aao3130","volume":"358","author":"J Drost","year":"2017","unstructured":"Drost, J. et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer. Science 358, 234\u2013238 (2017).","journal-title":"Science"},{"key":"2839_CR47","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1101\/gr.246223.118","volume":"29","author":"M Jager","year":"2019","unstructured":"Jager, M. et al. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer. Genome Res. 29, 1067\u20131077 (2019).","journal-title":"Genome Res."},{"key":"2839_CR48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17447-3","volume":"11","author":"K Voordeckers","year":"2020","unstructured":"Voordeckers, K. et al. Ethanol exposure increases mutation rate through error-prone polymerases. Nat. Commun. 11, 3664 (2020).","journal-title":"Nat. Commun."},{"key":"2839_CR49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nature25154","volume":"553","author":"JI Garaycoechea","year":"2018","unstructured":"Garaycoechea, J. I. et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature 553, 171\u2013177 (2018).","journal-title":"Nature"},{"key":"2839_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.03.026","author":"M Zhu","year":"2019","unstructured":"Zhu, M. et al. Somatic mutations increase hepatic clonal fitness and regeneration in chronic liver disease. Cell https:\/\/doi.org\/10.1016\/j.cell.2019.03.026 (2019).","journal-title":"Cell"},{"key":"2839_CR51","doi-asserted-by":"crossref","first-page":"107327481772924","DOI":"10.1177\/1073274817729245","volume":"24","author":"NN Massarweh","year":"2017","unstructured":"Massarweh, N. N. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control 24, 1073274817729245 (2017).","journal-title":"Cancer Control"},{"key":"2839_CR52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029\u20131041.e21 (2017).","journal-title":"Cell"},{"key":"2839_CR53","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","volume":"144","author":"V Hernandez\u2013Gea","year":"2013","unstructured":"Hernandez\u2013Gea, V., Toffanin, S., Friedman, S. L. & Llovet, J. M. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 144, 512\u2013527 (2013).","journal-title":"Gastroenterology"},{"key":"2839_CR54","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.cell.2016.07.045","volume":"166","author":"L Zhu","year":"2016","unstructured":"Zhu, L. et al. Multi-organ mapping of cancer risk. Cell 166, 1132\u20131146.e7 (2016).","journal-title":"Cell"},{"key":"2839_CR55","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41586-020-03147-x","volume":"590","author":"D Alonso-Curbelo","year":"2021","unstructured":"Alonso-Curbelo, D. et al. A gene-environment-induced epigenetic program initiates tumorigenesis. Nature 590, 642\u2013648 (2021).","journal-title":"Nature"},{"key":"2839_CR56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nprot.2017.111","volume":"13","author":"M Jager","year":"2018","unstructured":"Jager, M. et al. Measuring mutation accumulation in single human adult stem cells by whole-genome sequencing of organoid cultures. Nat. Protoc. 13, 59\u201378 (2018).","journal-title":"Nat. Protoc."},{"key":"2839_CR57","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210\u2013216 (2019).","journal-title":"Nature"},{"key":"2839_CR58","doi-asserted-by":"publisher","unstructured":"Nguyen, L. Precancerous liver diseases do not cause increased mutagenesis in liver stem cells. https:\/\/doi.org\/10.5281\/zenodo.5562381. (2021).","DOI":"10.5281\/zenodo.5562381"},{"key":"2839_CR59","doi-asserted-by":"publisher","unstructured":"Nguyen, L. UMCUGenetics\/Diseased_livers: natcomm_submission. https:\/\/doi.org\/10.5281\/zenodo.5564971. (2021).","DOI":"10.5281\/zenodo.5564971"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02839-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02839-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02839-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T19:59:20Z","timestamp":1670097560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02839-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2839"],"URL":"https:\/\/doi.org\/10.1038\/s42003-021-02839-y","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1301"}}